Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2026-09-16 16:01:10 ET · period of report 2026-09-15 · accession 0001683168-26-007192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 16:01 | 2026-09-15 | PHIO | BRADFORD PATRICIA A | Dir | P - Purchase | $1.03 | +12.0K | 57.7K | +26% | +$12.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.0001 par value | 2026-09-15 | P | A | 12,000 | $1.03 | 57,651 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |